Background Population trends in PSA testing and prostate cancer incidence do not perfectly
correspond. We aimed to better understand relationships between trends in PSA testing …

Simple Summary Prostate cancer is a major cause of cancer-related death in men
worldwide. There is an urgent clinical need for improved prognostic biomarkers to better …

Background Optimal prostate cancer (PCa) screening strategies will focus on men likely to
have potentially lethal disease. Age‐specific incidence rates (ASIRs) by modern clinical risk …

The aim of the study was to evaluate prognosis for biochemical recurrence (BR) by
analysing the pathological and biological characteristics of prostate cancer (PCa) after …

To compare the effectiveness at ten years of follow-up of radical prostatectomy,
brachytherapy and external radiotherapy, in terms of overall survival, prostate cancer …

Background: Previous studies documenting variations in severity of prostate cancer at
diagnosis by race/ethnicity and insurance status have been limited to small sample sizes …

Purpose: Irreversible electroporation is a tissue ablation modality that uses high voltage
electric energy to induce an increase in cell membrane permeability. This causes …

Background Localized prostate cancer is clinically heterogeneous, despite clinical risk
groups that represent relative prostate cancer-specific mortality. We previously developed a …

Background: While randomized controlled trials represent the highest level of evidence we
can generate in comparative effectiveness research, there are clinical scenarios where this …

BACKGROUND: Initial treatment options for low-risk clinically localized prostate cancer
(PCa) include radical prostatectomy (RP) or observation. OBJECTIVE: To examine cancer …